REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

ESZAK PHARMA Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: ESZAK PHARMA Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

ESZAK PHARMA Kft. is a company in Hungary, with a head office in Recsk. It operates in the Pharmacies and Drug Stores industry. It was first established on September 30, 2018. ESZAK PHARMA Kft. currently employs 7 (2024) people. In 2023, the company reported a net sales revenue increase of 12.17%. Its total assets grew by 70.12% over the same period. In 2023, ESZAK PHARMA Kft.’s net profit margin increased by 0.2%.

Headquarters
Varbukki ut 2.
Recsk; Heves; Postal Code: 3245

Contact Details: Purchase the ESZAK PHARMA Kft. report to view the information.

Basic Information
Total Employees:
Purchase the ESZAK PHARMA Kft. report to view the information.
Outstanding Shares:
Purchase the ESZAK PHARMA Kft. report to view the information.
Registered Capital:
Purchase the ESZAK PHARMA Kft. report to view the information.
Financial Auditors:
Purchase the ESZAK PHARMA Kft. report to view the information.
Incorporation Date:
September 30, 2018
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after ESZAK PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
12.17%▲
Total operating revenue
13.27%▲
Operating profit (EBIT)
16.63%▲
EBITDA
16.62%▲
Net Profit (Loss) for the Period
14.75%▲
Total assets
70.12%▲
Total equity
6.03%▲
Operating Profit Margin (ROS)
0.38%▲
Net Profit Margin
0.2%▲
Return on Equity (ROE)
3.36%▲
Quick Ratio
2.38%▲
Cash Ratio
2.81%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo